D.E. Shaw & Co’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-10,000
Closed -$295K – 4812
2022
Q4
$295K Hold
10,000
– – ﹤0.01% 4094
2022
Q3
$418K Hold
10,000
– – ﹤0.01% 4137
2022
Q2
$281K Hold
10,000
– – ﹤0.01% 4391
2022
Q1
$371K Hold
10,000
– – ﹤0.01% 4541
2021
Q4
$437K Hold
10,000
– – ﹤0.01% 4474
2021
Q3
$621K Hold
10,000
– – ﹤0.01% 3951
2021
Q2
$854K Buy
+10,000
New +$536K ﹤0.01% 3673

Other funds holding FLNA

D.E. Shaw & Co's FLNA Position: Q3 2026 in Review

D.E. Shaw & Co sold out of Filana Therapeutics (FLNA) in Q3 2026, closing a stake of 485,025 shares — an estimated $577K sold.

D.E. Shaw & Co first reported a position in FLNA in Q2 2013 and held it in 30 quarters. The position peaked at $5.13M in Q2 2021. 79 funds tracked by Wall St. Rank hold FLNA as of Q3 2026.

  • D.E. Shaw & Co reported no remaining Filana Therapeutics position as of Q3 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 485,025 Filana Therapeutics shares in Q3 2026, an estimated $577K.
  • D.E. Shaw & Co first reported a position in Filana Therapeutics in Q2 2013 and held it in 30 quarters.
  • D.E. Shaw & Co's Filana Therapeutics position peaked at $5.13M in Q2 2021.
  • 79 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.